Fallows, E and Ells, L and Anand, V
(2023)
Semaglutide and the future of obesity care in the UK.
Lancet, 401 (10394).
pp. 2093-2096.
ISSN 1474-547X
DOI: https://doi.org/10.1016/S0140-6736(23)01083-8
More Information
Identification Number: | https://doi.org/10.1016/S0140-6736(23)01083-8 |
---|---|
Status: | Published |
Refereed: | Yes |
Uncontrolled Keywords: | Humans, Glucagon-Like Peptides, Obesity, United Kingdom, 11 Medical and Health Sciences, General & Internal Medicine, |
Depositing User (symplectic) | Deposited by Campbell, Amy on behalf of Ells, Louisa |
Date Deposited: | 31 Jul 2023 09:29 |
Last Modified: | 14 Jul 2024 09:44 |
Item Type: | Article |
Download
Accepted Version
Note: this is the author's final manuscript and may differ from the published version which should be used for citation purposes.
License: Creative Commons Attribution Non-commercial No Derivatives
| Preview
Note: this is the author's final manuscript and may differ from the published version which should be used for citation purposes.
License: Creative Commons Attribution Non-commercial No Derivatives
| Preview
Export Citation
Explore Further
Read more research from the author(s):